Work

Postoperative Noninvasive Ventilation

Year: 2010
Type: review
Abstract: POSTOPERATIVE hypoxemia and/or acute respiratory failure (ARF) mainly develop after abdominal and/or thoracic surgery.1Anesthesia, postoperative pain, and surgery will induce respiratory modifications: hypoxemia, decrease in pulmonary volume, and atelectasis1associated with a restrictive syndrome and a diaphragm dysfunction.2These modifications of the respiratory function occur early after surgery and are more often transient and could lead to ARF. The clinical result (severity of the ARF) is the product of perioperative-related ventilatory impairment and severity of the preoperative pulmonary condition. Maintenance of adequate oxygenation in the postoperative period is of major importance, especially when pulmonary complications such as ARF occur. Although invasive endotracheal mechanical ventilation has remained the cornerstone of ventilatory strategy for many years for severe ARF, several studies have shown that mortality associated with pulmonary disease is largely related to complications of postoperative reintubation and mechanical ventilation. Therefore, major objectives for anesthesiologists are first to prevent the occurrence of postoperative complications and second to ensure oxygen administration and carbon dioxide removal while avoiding intubation if ARF occurs. Noninvasive ventilation (NIV) does not require an artificial airway (endotracheal tube or tracheotomy), and its use is well established to prevent ARF occurrence (prophylactic treatment) or to treat ARF to avoid reintubation (curative treatment) (fig. 1). Studies show that patient-related risk factors, such as chronic obstructive pulmonary disease, age older than 60 yr, American Society of Anesthesiologists class of II or higher, obesity, functional dependence, and congestive heart failure, increase the risk for postoperative pulmonary complications.1–4Pulmonary conditions are a key problem for patients who require high-risk surgery for ventilatory function. Then postoperative NIV should be beneficial to these patients at high risk, especially after “aggressive” surgery.Rationale for postoperative NIV use is the same as the postextubation NIV use5plus the specificities due to the respiratory modifications induced by surgery and anesthesia. Postoperative NIV improves gas exchange, decreases work of breathing, and reduces atelectasis.The aims of this article are (1) to review the main respiratory modifications induced by surgery and anesthesia, which justify postoperative NIV use, (2) to offer some recommendations to safely apply postoperative NIV, and (3) to present the results obtained with preventive and curative NIV in a surgical context.The efficacy of NIV was first demonstrated for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease,6followed by a broader use for other kinds of ARF of various etiologies including acute cardiogenic pulmonary edema after solid organ transplant and in immunosuppressed hematology patients.6NIV therapy is increasingly popular for the treatment of the fore cited ARF and for new indications such as improvement of preoxygenation before intubation7,8and postoperative ARF.9–11This widening of indications has been accompanied by the improvement and development of ventilation techniques led by physicians and manufacturers. In 2009, the NIV use in the postoperative period is difficult to estimate, but 69% of French intensivists declared that they use it for first-line treatment of postoperative ARF and 54% to treat postoperative atelectasis.12More recently, some authors have reported the feasibility and safety of NIV use in the recovery room after various types of surgery.13Major changes in respiratory function occur in all patients after thoracic and abdominal surgery because of anesthetic and surgical consequences (more so as the site of the surgery approaches the diaphragm). Anesthetic decreases muscle tone that increases lung retractile forces and thus contributes to atelectasis development.2Surgery disrupts abdominal, thoracic, and diaphragmatic muscles forces, reduces phrenic output, and induces pain. Taken together, these changes alter the ventilation/perfusion ratio that leads to hypoxemia. These early and transitory modifications of respiratory function may lead to respiratory failure affecting the “pump” function (respiratory muscles) and the “exchange” function (lungs).1Moreover, perioperative-related modifications of the ventilatory system and hypoxemia that were frequently observed in the early postoperative period may be aggravated by other factors, such as excessive perioperative vascular loading,14transfusion-related acute lung injury, inflammation, sepsis, and aspiration.Clinical arguments in favor of postoperative NIV are the same as those for using NIV in postextubation period5as well as for the respiratory modifications caused by surgery and anesthesia. NIV should supply pump function and improves gas exchange. The main respiratory modifications are maximum in the first hours after surgery and generally regress after 1–2 weeks.1,2The expected benefit of NIV would be to partially compensate for the affected respiratory function by reducing the work of breathing, by improving alveolar ventilation associated with increased gas exchange, reducing left ventricular afterload with increase of cardiac output, and by reducing atelectasis (fig. 2).NIV delivering positive pressure refers to techniques that permitted ventilatory support to patients without an endotracheal airway, that is, using nasal, facial, or helmet interfaces. Two types of NIV are commonly used: (1) CPAP is a method that delivers noninvasively constant positive airway pressure during both inspiration and expiration, either by use of a flow generator with a high pressure gas source or by use of a portable compressor to spontaneously breathing patients. When CPAP is applied with positive inspiratory PSV, it is referred to as PEEP (in fact CPAP and PEEP are the same entity in clinical application) and (2) BIPAP refers to the association of PSV + PEEP. Definitions and taxonomy of noninvasive ventilatory assist techniques are often confused. NIV is often assimilated to a noninvasive delivered BIPAP (i.e. , PSV + PEEP) technique that delivered two positive airway pressures. In fact, NIV includes PSV + PEEP and CPAP, in which the later delivered only one positive airway pressure.The underlying mechanism by which CPAP exerts its effects is to increase intrathoracic pressure. This way, CPAP prevents airway and alveolar collapse, prevents atelectasis, maintains functional residual capacity, and reduces left ventricular afterload with increase in cardiac output. Moreover, CPAP also permitted to decrease work of breathing by counterbalancing the inspiratory threshold load imposed by intrinsic PEEP in some patients (i.e. , chronic obstructive pulmonary disease). Clinical improvements caused via an improved cardiac function are sometimes difficult to distinguish from the pulmonary effects of CPAP in postoperative period.PSV is a ventilatory mode in which the patient's spontaneous inspiratory effort triggers the ventilator to provide a variable flow of gas that increases until airway pressure reaches a selected level. Thus, during each spontaneous inspiration, the patient receives a pressure-supported breath. Once the selected airway pressure is achieved, the patients can continue to breathe until their inspiratory flow rate drops below a threshold level in the absence of leaks (usually a fixed level at 25% of the peak flow). Thus, the tidal volume achieved depends on patient's respiratory compliance and the patient's own effort added to that of the ventilator's inspiratory pressure, which can be capped at a relatively low level. The main singularity of PSV mode is that the patients control not only their respiratory rate but also their inspiratory and expiratory times. PSV has been widely used as partial ventilatory support to improve patient–ventilator synchrony and then the comfort. Ventilator settings should be adjusted to provide the lowest inspiratory pressures or volumes needed to produce improved patient comfort (a decrease in respiratory rate and respiratory muscle unloading) and gas exchange.We can consider that CPAP used alone essentially helps to provide satisfactory gas exchange through changes in ventilation/perfusion ratio and increase in oxygen partial alveolar pressure. PSV above PEEP, as compared with CPAP, provides a better physiologic response in terms of muscle unloading and dyspnea relief. PSV + PEEP ensures alveolar ventilation, whereas CPAP alone does not. Then, it is difficult to recommend a single combination PSV/PEEP for all patients, and probably an individual titration should be performed to find the best NIV setting to reduce dyspnea, unload respiratory muscles, and increase oxygenation.Initially, the clinical experience reported in postsurgical patients was limited to the use of CPAP alone. Moreover, in these studies,15CPAP was used to prevent ARF after surgery (prophylactic use, i.e. , immediately after extubation, not waiting for patients to develop respiratory distress) but not to treat ARF once it developed (curative use).15However, studies of ARF in the postoperative setting have shown favorable results for both NIV practice PSV + PEEP and CPAP.Postoperative NIV can be proposed in two ways (fig. 1). The first is a preventive or “prophylactic” application to prevent postoperative ARF from developing in patients at risk (elderly, obese, chronic obstructive pulmonary disease, and heart disease) and the second consists of a “curative” application, once ARF occurs, to alleviate respiratory failure while avoiding tracheal intubation, a cause of increased morbidity. Nevertheless, NIV (PSV + PEEP or CPAP) should never be initiated in confused patients, those unable to cooperate, or with hemodynamic instability. Moreover, tracheal intubation should never be delayed if respiratory status worsened despite CPAP or PSV + PEEP ventilatory support. Two multicenter randomized studies16,17reported that NIV is not effective for the management of postextubation respiratory failure in nonselected patients (curative use), and delayed reintubation may increase mortality.16In contrast, randomized studies5,18showed that the early use of NIV can prevent respiratory failure after extubation and decrease the need for reintubation in selected patients considered at risk for postextubation respiratory failure (preventive use).NIV works best in patients relaxed and prepared. CPAP pressures of 7–10 cm H2O are required to keep tracheal pressure positive during the entire respiratory cycle and to consistently improve gas exchange. These CPAP pressures are safe, and no adverse hemodynamic effects were observed. In PSV + PEEP, patient comfort and interface acceptance may be gained by starting with PEEP alone and then slowly increasing the PSV level once the mask is applied (fig. 3). We recommend starting with a PSV of 3–5 cm H2O and increasing in increments of 2 cm H2O to achieve a 6–10 ml/kg expiratory tidal volume, a decrease in the patient's respiratory rate, and a comfort improvement11(fig. 3). The PEEP is started at 3–5 cm H2O and increased as needed to improve oxygenation without adverse hemodynamic effects up to 10 cm H2O. The insufflation pressure (PSV + PEEP level) applied should be less than 25 cm H2O. These setting recommendations are based solely on clinical experience without any formal data to support the superiority of one technique over another.6A surgical complication arises in nearly half the cases of ARF. The treatment is usually reintervention, management of ARF is only symptomatic, and there is no reason to use NIV to avoid intubation because the patient requires intubation for anesthesia.Evidence to guide duration of NIV trial is lacking; hence, the recommendations are based largely on practitioner experience. In postoperative area, we recommended “sequential” use wherein periods of use alternate with lengthy ventilator-free periods, and total daily use ranges between 3 and 12 h depending on the type of application (curative or prophylactic use). In our practices,11during the first 24 h, for the majority of the patients, NIV was applied for approximately 30–45 min at 2- to 4-h intervals (prophylactic), depending on the patient's clinical condition. Some patients were treated during the initial period with NIV for 60–90 min at 2- to 3-h intervals (range, 8–12 h/day; curative). Between the periods of NIV, the patients breathed through a Venturi mask. The length of NIV cycles was progressively reduced and was withdrawn completely, as blood gas values and clinical condition improved.Both intensive care unit (ICU) and portable ventilators can be used for postoperative NIV, and to date, no study has demonstrated superiority of one type over the other.19However, devices using a common inspiratory and expiratory line can cause rebreathing of exhaled gases and persistent hypercapnia.20ICU ventilators were originally designed to ventilate intubated patients, that is, with minimal or no leaks, and fare less well in their presence.19Because, ICU ventilators have been increasingly used for NIV over the years and the presence of leaks at the patient–ventilator interface interferes with several key ventilator functions, manufacturers offer in the recent generations of ICU ventilators NIV-specific mode dedicated to preventing these problems.19Larger leaks from around the mouth are irritating to the patient and trigger insensitivity and prolonged expiratory time, ultimately resulting in patient–ventilator asynchrony. The tight fitting of a properly selected NIV mask reduces the magnitude of leaks (usually ranged between 20 and 40%), but this measure alone often proves insufficient and can be limited by skin complications and patient discomfort. The majority of ventilators using PSV mode have a cycling mechanism based on the achievement of a preset flow threshold (i.e. , 25% of peak inspiratory flow), which may be not functional in the presence of leaks. In the most recent ventilator generations, the preset flow threshold of cycling and the inspiratory time can be set by a user to avoid prolonged inspiratory time. Other alternatives to provide a better patient–ventilator interaction (except optimize the interface, see next section) are to use a preset limited inspiratory time or to use a time-cycled rather than a flow-cycled expiratory trigger, by using pressure-controlled ventilation mode, which is pressure limited and time cycled. The new NIV modes (or options) provide PSV with leak compensation, which aims to minimize the impact of leaks on key ventilator functions (mainly inspiratory and expiratory triggers).19The leak compensation mechanism varied between ventilators, and it depends of the software developed by each manufacturer.19Briefly, the rationale of NIV leak compensation consists of recording continuous leaks evaluated by measuring the difference between inspiratory and expiratory tidal volumes. The microprocessor of ventilator already assesses inspiratory and expiratory flow (then volume) and pressure continuously and it retains these informations in memory. Then, to compensate for a significant leak, the ventilator will increase peak inspiratory flow rates without prolonged inspiratory time, which is counterproductive by inducing patient–ventilator asynchrony. Modern pressure ventilators can compensate for very large leaks up to 180 l/min.The main difference between invasive and NIV is that with the latter technique, gas is delivered to the airway via an interface or rather than an invasive tube (endotracheal or with variable leaks. interface that properly is in leaks and NIV for and types of at the are to the best for each The first should be used to the mask and the patient with the may especially when increasing respiratory and when difficult breathing is NIV is best when pressures are increased as the work of breathing and respiratory (fig. 3). The of interface is very when NIV and more so in the presence of a if the patient's and the tube lead to increased leaks, the NIV of several to trial for each patient to one with minimal date, there is no to support the use of patient interface devices in surgical Then, should mask and types in an effort to patient without absence of hemodynamic and to are to the application and the of The and of NIV use are reported in When NIV is the patients be and should be to their level of dyspnea, respiratory rate, and oxygen be for of ventilator mask leaks, and skin especially at the requires with early postoperative NIV was for In fact, there is a risk of insufflation when high insufflation pressures are applied (PSV + PEEP 25 cm the risk of due to NIV settings may be by CPAP over PSV use is the PSV level be below cm H2O. Moreover, compared with NIV using PSV + PEEP, CPAP is to especially ICU and/or in PSV + PEEP be is that the more the and/or the the the rate of PSV + PEEP. in some patients, CPAP and PSV + PEEP may be applied in to improve and/or presence of a tube after surgery may increase leaks around the mask during Some manufacturers have proposed to leaks around the mask with These should be evaluated in clinical is recommended to keep the tube on a rather than in to In of the will that the NIV and the use of NIV need to be for patients NIV is ICU or recovery depends on the for adequate and experience in the their of the and of restrictive syndrome to cardiac surgery is generally less severe than that observed after thoracic or abdominal the of diaphragm is studies mainly compared CPAP with treatment + of these studies reported improved oxygenation and ventilation of these studies any in the of atelectasis in the treated by NIV, in fact CPAP, for a in lung when NIV was applied with CPAP alone or with PSV (PSV + a study including patients, evaluated NIV in the first 2 after were compared in randomized The first h of NIV with two pressure 3 h with an level of 12 cm H2O of PSV and cm H2O of PEEP. The second a of CPAP at cm H2O 3 h, and a 20 min of 2 NIV at one or two pressure permitted improved oxygenation and a of lung volumes. atelectasis was in all the of application of a trial of cm H2O CPAP with NIV (PSV 10 and PEEP in two of patients. The NIV improved less on was no significant difference in oxygenation in a randomized study patients for cardiac the of prophylactic CPAP of 10 cm H2O for at after surgery in with treatment including 10 min of CPAP at 10 cm H2O In the study CPAP improved reduced the of pulmonary complications including and reintubation rate, and reduced rate to ICU or care our at the time of no study has been the of curative NIV in patients who have developed ARF after cardiac a physiologic the effects of a NIV trial after pulmonary in 10 patients. NIV was applied without any complications due to the technique and improved oxygenation without increasing leaks around thoracic in the study compared with a control who not in a randomized clinical trial the of NIV and were required to treatment without or with NIV during at before surgery and during 3 In this h after oxygenation and lung volumes values were better in the NIV and oxygenation was improved in the NIV The was in the control than in the NIV This first randomized that prophylactic use of NIV in a and postoperative reduces pulmonary after lung an their experience of NIV after lung transplant in patients who developed ARF. of NIV was for all of the patients treated were to avoid a randomized study including 24 patients in each the of NIV in ARF after lung In this was delivered by a mask using a single ventilator and compared with treatment + + reducing the need for invasive mechanical ventilation and mortality in an the feasibility and efficacy of early NIV in ARF after lung a patients at risk of severe complications after lung ARF, which was by The rate of NIV was the recovery of of patients after abdominal those that a CPAP in patients by permitted a significant improvement in of atelectasis compared with treatment by surgery for obesity, a significant of the restrictive syndrome and significant improvement in oxygenation evaluated by with NIV applied for of the first postoperative 24 with the control was improved only with a high PSV level of 12 cm because treated with a PSV level of cm H2O not have a significant improvement of functional residual This the increase in the rate of surgery the of a CPAP of 10 cm H2O for h a after surgery of The of patients CPAP improved oxygenation and a ICU and than those in the control large early because of improvements in intubation related to CPAP therapy in patients after abdominal This randomized patients in two one CPAP and a control oxygen via a mask. The patients CPAP intubation, and rates than the control from postoperative ARF have been other types of patients in studies NIV to treat ARF of these no has been between patients with ARF of and those with postoperative ARF, probably because of the and of patients the feasibility of NIV in postoperative ARF in patients and was in of patients in this a that CPAP improved oxygenation and intubation in of 20 patients treated after abdominal and/or thoracic in an study their experience over a period using NIV in patients with severe ARF after In this was in of patients. This and safety of NIV for the treatment of ARF after severe initial hypoxemia and improvement of NIV were of NIV results obtained in the study by was by a recent study that patients who developed ARF after abdominal surgery and patients intubation a study compared the efficacy of NIV delivered by a helmet interface and a mask in patients with ARF after abdominal These authors reported an NIV rate of in the helmet and of in the mask in a randomized trial that in organ transplant with ARF, NIV reduced the rate of intubation, the of and ICU mortality compared with the of oxygenation alone. recently, in a study the efficacy of NIV with treatment in patients who developed postoperative ARF after that the use of NIV was associated with a intubation rate, of acute respiratory and a in ICU length of of the presence of thoracic and/or abdominal surgery and the respiratory system for ventilation through an endotracheal tube may be for and the NIV has to be an effective strategy to reduce intubation ICU and of and and mortality in patients with either or ARF. before NIV in postoperative period in patients with ARF, a surgical complication sepsis, and should be and Then, if patients are and to their airway, NIV can be initiated of the safety and of The application of postoperative NIV by a and ICU with patient should optimize patient authors are to for
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2043723454
FWCI: 1.877
Cites: 38
Cited by: 219
Related to: 10